Tegoprazan-amoxicillin dual therapy
KY20240123-05
Unknown mab completed
Quick answer
Tegoprazan-amoxicillin dual therapy for Helicobacter Pylori Infection is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Helicobacter Pylori Infection
- Phase
- Unknown
- Modality
- mab
- Status
- completed